Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Click Here if you want to upgrade your account
If you were able to post but cannot do so now, send an email to admin at raypeatforum dot com and include your username and we will fix that right up for you.
kiran said:Such_Saturation said:For some reason cyproheptadine can't be taken with monoamine oxidase inhibitors.
http://www.webmd.com/drugs/2/drug-8879/ ... rtype-drug
How the interaction occurs:
Monoamine oxidase inhibitors (MAOIs) may increase the effects of your antihistamine.
What might happen:
Your blood pressure may drop dangerously low.
Such_Saturation said:kiran said:Such_Saturation said:For some reason cyproheptadine can't be taken with monoamine oxidase inhibitors.
http://www.webmd.com/drugs/2/drug-8879/ ... rtype-drug
How the interaction occurs:
Monoamine oxidase inhibitors (MAOIs) may increase the effects of your antihistamine.
What might happen:
Your blood pressure may drop dangerously low.
Then I guess people should avoid cyproheptadine with this stuff before anything bad happens.
The Thorne combo only has 1mg MK4 every fifteen drops, so you're better off with the Life Extension product at that point.
The fact that vitamin A would pose the same dangers as PUFA seems odd to me, since in plants carotenoids are used to <<protect plant tissues by helping to absorb the energy from singlet oxygen, an excited form of the oxygen molecule O2 which is formed during photosynthesis>> and <<they protect chlorophyll from photodamage.>> [http://en.wikipedia.org/wiki/Carotene] [http://en.wikipedia.org/wiki/Carotenoid]
haidut said:I would not say it poses the same danger as PUFA, but it can suppress metabolism (conversion of T4 into T3) in higher doses if not taken with adequate vitamin E (100 IU vitamin E per every 100,000 IU of vitamin A). Ray has said vitamin A can be very anti-thyroid if not controlled properly, and also very pro-thyroid if used properly.
Nice!ken said:Has anyone come across this page? Kind of a summation of the various threads. http://augmentationlimitless.blogspot.c ... -blue.html
Greg says said:What about taking MB with Tianeptine? I started taking MB and stopped after a few days as I noticed when I moved my eyes from left to right, right to left, it really jolted. I experienced this when I used to take SSRIs.
Charlie said:Methylene blue is giving me blurred vision, and dry eyes. I have stopped so hopefully that will go away.
Are you using it topically for the fungal issue or just through normal supplementation orally?artemis said:That was my main reason for trying it. I have not been real consistent with it, though. Have also added it to my bathwater about 5 or 6 times in the past few weeks. Looks so cool!
The fungal issue is definitely improving (could be due to many other things, too)
Still trying to work out whether the psychological effects are placebo or not. They are very subtle, for me, and feel a lot like the effects from caffeine, thyroid, etc.
But it's all good so far -- never anything undesirable.
messtafarian said::). This is kind of funny. I asked doc p about my herniated cervical disc and cervical spondylosis. So he wrote back and said that it happens with low thyroid and an imbalance of DHEA to cortisol. He said aspirin and pregnenolone might help. This was the reference he included:
Pain. 2010 Apr;149(1):124-9.
A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain.
Peng B 1, Pang X, Wu Y, Zhao C, Song X.
A preliminary report of clinical study revealed that chronic discogenic low back pain could be treated by intradiscal methylene blue (MB) injection. We investigated the effect of intradiscal MB injection for the treatment of chronic discogenic low back pain in a randomized placebo-controlled trial. We recruited 136 patients who were found potentially eligible after clinical examination and 72 became eligible after discography. All the patients had discogenic low back pain lasting longer than 6 months, with no comorbidity. Thirty-six were allocated to intradiscal MB injection and 36 to placebo treatment. The principal criteria to judge the effectiveness included alleviation of pain, assessed by a 101-point numerical rating scale (NRS-101), and improvement in disability, as assessed with the Oswestry Disability Index (ODI) for functional recovery. At the 24-month follow-up, both the groups differed substantially with respect to the primary outcomes. The patients in MB injection group showed a mean reduction in pain measured by NRS of 52.50, a mean reduction in Oswestry disability scores of 35.58, and satisfaction rates of 91.6%, compared with 0.70%, 1.68%, and 14.3%, respectively, in placebo treatment group (p<0.001, p<0.001, and p<0.001, respectively). No adverse effects or complications were found in the group of patients treated with intradiscal MB injection. The current clinical trial indicates that the injection of methylene blue into the painful disc is a safe, effective and minimally invasive method for the treatment of intractable and incapacitating discogenic low back pain.
Copyright 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
messtafarian said:Narouz, if my neck wasn't so close to my brain I'd slap some right on top of the c5 vertebrae :)